One-hundred forty-six SCLC patients were classified as localised (56)
or extensive (90) using chest X-ray, bronchoscopy, brain CT, bone scin
tigraphy, ultrasonography of the abdomen and bilateral bone marrow tre
phine biopsy. Bone marrow metastases were found in 28 cases. Patients
with bone marrow metastases had significantly shorter time to progress
ion (median 20 weeks) and significantly shorter survival time (median
31 weeks) than other patients with extensive disease (medians 30 and 4
6 weeks). Patients with bone marrow involvement had significantly more
often metastases in three or more organs than others with extensive d
isease. The negative prognostic significance of bone marrow involvemen
t was however independent of the negative prognostic significance of t
he number of organs with metastases.